Comparison of Long vs. Short Acting Anesthesia for Improving Pain Management After Breast Biopsy
Withdrawn before enrolling · Phase 4
Conditions studied: Pain Management After Breast Biopsy
In brief
This study will evaluate the potential role of a long acting anesthetic (ropivacaine) in providing an extended period of pain relief for patients undergoing ultrasound guided core biopsy of the breast.
Key facts
- Study ID
- NCT02085239
- Run by
- TriHealth Inc.
- People needed
- 0
- Starts
- 2013-08-01
- Expected to finish
- 2015-03-01
- Last updated by the study team
- 2018-09-12
Who can join
Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients with breast lesions recommended for biopsy by physician
You may not qualify if…
- Patients with breast lesions not recommended for biopsy
- Patients with allergic reactions to lidocaine, ropivacaine, or related anesthetics
Where it is running
- Mary Jo Cropper Family Center for Breast Care; Bethesda North Hospital — Cincinnati, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.